Sequential Cystatin C Levels and Renal Impairment in Acute Heart Failure
Sponsor: The Cleveland Clinic
This observational or N/A phase trial investigates Acute Heart Failure and Renal Failure and is currently completed. The Cleveland Clinic leads this study, which shows 13 recorded versions since 2007 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Change History
13 versions recorded-
Dec 2025 — Present [monthly]
Completed
-
Jan 2025 — Dec 2025 [monthly]
Completed
-
Sep 2024 — Jan 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
▶ Show 8 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Jun 2018 — Nov 2020 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
-
Feb 2017 — Aug 2017 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Jan 2017 — Feb 2017 [monthly]
Unknown Status NA
First recorded
Dec 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- The Cleveland Clinic
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Cleveland, United States